5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.01▲ | 2.06▼ | 2.06▼ | 2.14▼ | 2.30▼ |
MA10 | 2.03▼ | 2.07▼ | 2.10▼ | 2.18▼ | 2.31▼ |
MA20 | 2.06▼ | 2.12▼ | 2.14▼ | 2.33▼ | 2.21▼ |
MA50 | 2.12▼ | 2.15▼ | 2.17▼ | 2.37▼ | 2.25▼ |
MA100 | 2.15▼ | 2.23▼ | 2.31▼ | 2.12▼ | 4.61▼ |
MA200 | 2.25▼ | 2.39▼ | 2.36▼ | 2.15▼ | 37.28▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.003▼ | -0.008▼ | -0.012▼ | -0.032▼ | 0.025▲ |
RSI | 34.199▼ | 33.738▼ | 35.389▼ | 32.798▼ | 46.418▼ |
STOCH | 6.389▼ | 7.540▼ | 4.798▼ | 28.124 | 25.307 |
WILL %R | -75.000▼ | -87.879▼ | -92.308▼ | -98.075▼ | -83.050▼ |
CCI | -66.027 | -134.148▼ | -162.928▼ | -135.422▼ | -78.340 |
Friday, August 15, 2025 03:40 AM
Phio Pharmaceuticals (NASDAQ:PHIO) announced that certain selling stockholders plan to resell up to 1.93 million shares of its common stock, primarily from the potential exercise of previously issued ...
|
Thursday, August 14, 2025 03:49 PM
August 14, 2025) – Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biopharmaceutical company developing therapeutics using its proprietary INTASYL ® siRNA gene silencing technology to ...
|
Thursday, August 14, 2025 03:16 PM
Key Points GAAP EPS for Q2 2025 missed analyst estimates, with a GAAP net loss of $2.2 million and a GAAP EPS of $(0.45). Clinical progress for lead candidate PH-762 showed positive safety and early ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
19/08/25 | 2.13 | 2.13 | 2.00 | 2.01 | 283,761 |
18/08/25 | 2.18 | 2.20 | 2.09 | 2.15 | 67,553 |
15/08/25 | 2.05 | 2.26 | 2.05 | 2.18 | 173,048 |
14/08/25 | 2.25 | 2.285 | 2.12 | 2.19 | 138,297 |
13/08/25 | 2.10 | 2.24 | 2.05 | 2.19 | 169,161 |
12/08/25 | 2.17 | 2.18 | 2.03 | 2.14 | 136,855 |
11/08/25 | 2.22 | 2.26 | 2.09 | 2.13 | 194,443 |
08/08/25 | 2.24 | 2.28 | 2.20 | 2.25 | 170,993 |
07/08/25 | 2.26 | 2.3243 | 2.19 | 2.25 | 161,551 |
06/08/25 | 2.30 | 2.36 | 2.2601 | 2.33 | 122,819 |
|
|
||||
|
|
||||
|
|